Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
72.37
-0.04 (-0.06%)
At close: Sep 18, 2026, 4:00 PM EDT
72.43
+0.05 (0.08%)
After-hours: Sep 18, 2026, 7:34 PM EDT
Bio-Techne Market Cap
Bio-Techne has a market cap or net worth of $11.35 billion as of September 18, 2026. Its market cap has increased by 41.62% in one year.
Market Cap
11.35B
Enterprise Value
11.37B
1-Year Change
41.62%
Ranking
Category
Stock Price
$72.37
ChartMarket Cap Chart
Since December 1, 1998, Bio-Techne's market cap has increased from $355.80M to $11.35B, an increase of 3,089.70%. That is a compound annual growth rate of 13.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 11.35B | 23.85% |
| Dec 31, 2025 | 9.16B | -19.94% |
| Dec 31, 2024 | 11.45B | -6.21% |
| Dec 29, 2023 | 12.20B | -6.20% |
| Dec 30, 2022 | 13.01B | -36.00% |
| Dec 31, 2021 | 20.33B | 65.81% |
| Dec 31, 2020 | 12.26B | 46.55% |
| Dec 31, 2019 | 8.37B | 53.07% |
| Dec 31, 2018 | 5.47B | 12.61% |
| Dec 29, 2017 | 4.85B | 26.50% |
| Dec 30, 2016 | 3.84B | 14.62% |
| Dec 31, 2015 | 3.35B | -2.30% |
| Dec 31, 2014 | 3.43B | -1.84% |
| Dec 31, 2013 | 3.49B | 38.67% |
| Dec 31, 2012 | 2.52B | -0.35% |
| Dec 30, 2011 | 2.53B | 3.71% |
| Dec 31, 2010 | 2.44B | -4.63% |
| Dec 31, 2009 | 2.55B | 4.09% |
| Dec 31, 2008 | 2.45B | -6.00% |
| Dec 31, 2007 | 2.61B | 19.52% |
| Dec 29, 2006 | 2.18B | 0.16% |
| Dec 30, 2005 | 2.18B | 35.65% |
| Dec 31, 2004 | 1.61B | 3.50% |
| Dec 31, 2003 | 1.55B | 31.15% |
| Dec 31, 2002 | 1.18B | -22.59% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Summit Therapeutics | 13.80B |
| BridgeBio Pharma | 13.35B |
| BioMarin Pharmaceutical | 12.53B |
| Halozyme Therapeutics | 12.31B |
| Madrigal Pharmaceuticals | 12.22B |
| Corcept Therapeutics | 12.09B |
| Axsome Therapeutics | 11.10B |
| Krystal Biotech | 9.97B |